Authored by: Yang Fan Zhang Yunwei (Mark) Li Lingbi

When a newly registered pharmaceutical/medical device product is launched in China, the pharmaceutical/medical device companies are motivated to provide certain sample products or demonstration products (“Evaluation Products”) free of charge to Chinese health care organizations (“HCOs”) and/or health care professionals (“HCPs”) for evaluation purpose. On one hand, the Evaluation Products could help the HCPs better understand how the new product functions in practice and whether it is suitable for their patients.

Read More